Literature DB >> 19074551

FoxO1 mediates PTEN suppression of androgen receptor N- and C-terminal interactions and coactivator recruitment.

Qiuping Ma1, Wei Fu, Pengfei Li, Santo V Nicosia, Guido Jenster, Xiaohong Zhang, Wenlong Bai.   

Abstract

FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor. Their activity is negatively regulated by AKT-mediated phosphorylation. Our previous studies showed that the transcriptional activity of the androgen receptor (AR) was inhibited by PTEN in an AKT-sensitive manner. Here, we report the repression of the activity of the full-length AR and its N-terminal domain by FoxO1 and the participation of FoxO1 in AR inhibition by PTEN. Ectopic expression of active FoxO1 decreased the transcriptional activity of AR as well as androgen-induced cell proliferation and production of prostate-specific antigen. FoxO1 knock down by RNA interference increased the transcriptional activity of the AR in PTEN-intact cells and relieved its inhibition by ectopic PTEN in PTEN-null cells. Mutational analysis revealed that FoxO1 fragment 150-655, which contains the forkhead box and C-terminal activation domain, was required for AR inhibition. Mammalian two-hybrid and glutathione-S-transferase pull-down assays demonstrated that the inhibition of AR activity by PTEN through FoxO1 involved the interference of androgen-induced interaction of the N- and C-termini of the AR and the recruitment of the p160 coactivators to its N terminus and to the androgen response elements of natural AR target genes. These studies reveal new mechanisms for the inhibition of AR activity by PTEN-FoxO axis and establish FoxO proteins as important nuclear factors that mediate the mutual antagonism between AR and PTEN tumor suppressor in prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074551      PMCID: PMC2646622          DOI: 10.1210/me.2008-0147

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  49 in total

1.  Evaluation of ligand-dependent changes in AR structure using peptide probes.

Authors:  Ching-Yi Chang; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2002-04

Review 2.  Modulation of cellular apoptotic potential: contributions to oncogenesis.

Authors:  V Stambolic; T W Mak; J R Woodgett
Journal:  Oncogene       Date:  1999-11-01       Impact factor: 9.867

3.  Antagonism between PTEN/MMAC1/TEP-1 and androgen receptor in growth and apoptosis of prostatic cancer cells.

Authors:  P Li; S V Nicosia; W Bai
Journal:  J Biol Chem       Date:  2001-03-16       Impact factor: 5.157

4.  Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions.

Authors:  H H Zhao; R E Herrera; E Coronado-Heinsohn; M C Yang; J H Ludes-Meyers; K J Seybold-Tilson; Z Nawaz; D Yee; F G Barr; S G Diab; P H Brown; S A Fuqua; C K Osborne
Journal:  J Biol Chem       Date:  2001-05-15       Impact factor: 5.157

5.  A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR.

Authors:  Shivapriya Ramaswamy; Noriaki Nakamura; Isabelle Sansal; Louise Bergeron; William R Sellers
Journal:  Cancer Cell       Date:  2002-07       Impact factor: 31.743

6.  Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool.

Authors:  Pradeep Reddy; Lian Liu; Deepak Adhikari; Krishna Jagarlamudi; Singareddy Rajareddy; Yan Shen; Chun Du; Wenli Tang; Tuula Hämäläinen; Stanford L Peng; Zi-Jian Lan; Austin J Cooney; Ilpo Huhtaniemi; Kui Liu
Journal:  Science       Date:  2008-02-01       Impact factor: 47.728

7.  Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.

Authors:  J Thompson; F Saatcioglu; O A Jänne; J J Palvimo
Journal:  Mol Endocrinol       Date:  2001-06

8.  FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor.

Authors:  B He; J A Kemppainen; E M Wilson
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

9.  Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites.

Authors:  Daniel Gioeli; Scott B Ficarro; Jesse J Kwiek; David Aaronson; Mathew Hancock; Andrew D Catling; Forest M White; Robert E Christian; Robert E Settlage; Jeffrey Shabanowitz; Donald F Hunt; Michael J Weber
Journal:  J Biol Chem       Date:  2002-05-15       Impact factor: 5.157

10.  Formation of the androgen receptor transcription complex.

Authors:  Yongfeng Shang; Molly Myers; Myles Brown
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

View more
  32 in total

Review 1.  Transcriptional switches: chemical approaches to gene regulation.

Authors:  Lori W Lee; Anna K Mapp
Journal:  J Biol Chem       Date:  2010-02-10       Impact factor: 5.157

2.  Activation of FOXO1 is critical for the anticancer effect of methylseleninic acid in prostate cancer cells.

Authors:  Haitao Zhang; Jian Fang; Dian Yao; Yue Wu; Clement Ip; Yan Dong
Journal:  Prostate       Date:  2010-09-01       Impact factor: 4.104

Review 3.  The role of androgen and androgen receptor in skin-related disorders.

Authors:  Jiann-Jyh Lai; Philip Chang; Kuo-Pao Lai; Lumin Chen; Chawnshang Chang
Journal:  Arch Dermatol Res       Date:  2012-07-25       Impact factor: 3.017

4.  Isotretinoin and FoxO1: A scientific hypothesis.

Authors:  Bodo C Melnik
Journal:  Dermatoendocrinol       Date:  2011-07-01

Review 5.  Unraveling the role of FoxOs in bone--insights from mouse models.

Authors:  Maria Almeida
Journal:  Bone       Date:  2011-06-01       Impact factor: 4.398

Review 6.  Structural features discriminate androgen receptor N/C terminal and coactivator interactions.

Authors:  Emily B Askew; John T Minges; Andrew T Hnat; Elizabeth M Wilson
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

7.  The activity of the androgen receptor variant AR-V7 is regulated by FOXO1 in a PTEN-PI3K-AKT-dependent way.

Authors:  Sanjay N Mediwala; Huiying Sun; Adam T Szafran; Sean M Hartig; Guru Sonpavde; Teresa G Hayes; Perumal Thiagarajan; Michael A Mancini; Marco Marcelli
Journal:  Prostate       Date:  2012-07-20       Impact factor: 4.104

8.  Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer.

Authors:  Biswajyoti Sahu; Marko Laakso; Kristian Ovaska; Tuomas Mirtti; Johan Lundin; Antti Rannikko; Anna Sankila; Juha-Pekka Turunen; Mikael Lundin; Juho Konsti; Tiina Vesterinen; Stig Nordling; Olli Kallioniemi; Sampsa Hautaniemi; Olli A Jänne
Journal:  EMBO J       Date:  2011-09-13       Impact factor: 11.598

9.  Combination effects of dietary soy and methylselenocysteine in a mouse model of prostate cancer.

Authors:  Merrill J Christensen; Trevor E Quiner; Heather L Nakken; Edwin D Lephart; Dennis L Eggett; Paul M Urie
Journal:  Prostate       Date:  2013-02-06       Impact factor: 4.104

10.  FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants.

Authors:  Laura R Bohrer; Ping Liu; Jian Zhong; Yunqian Pan; James Angstman; Lucas J Brand; Scott M Dehm; Haojie Huang
Journal:  Prostate       Date:  2013-02-06       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.